e-learning
resources
Conferences
Lung Science Conference
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Presentation by an expert: IL17 and the development of inflammatory airway diseases
J. Kolls (Pittsburgh, United States of America)
Source:
Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Number:
30
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Kolls (Pittsburgh, United States of America). Presentation by an expert: IL17 and the development of inflammatory airway diseases. Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
Presentation by an expert: IL33 and onset of chronic lung disease
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013
Presentation by an expert: Role of basophils in allergic inflammation and protective immunity
Source: Lung Science Conference 2014 - Lung Inflammation and Immunity
Year: 2014
Neutrophils in chronic inflammatory airway diseases: can we target them and how?
Source: Eur Respir J 2010; 35: 467-469
Year: 2010
Pro-inflammatory cytokines in pathogenesis professional occupetional pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 148s
Year: 2004
Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Interleukin-33 and Th2 cytokines correlate in acute asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
Targeting TNF-alpha in inflammatory lung diseases
Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes
Year: 2005
Systemic cytokine signaling via IL-17 and its relation to clinical characteristics in children with asthma
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015
Presentation by an expert: Impaired control of infection in the allergic lung microenvironment
Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease
Year: 2011
Presentation by an expert: Interactions between innate immunity, inflammation and structural cells in pulmonary disease
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013
Presentation by an expert: Early influences of the airway microbiome on obstructive lung disease
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013
Pathology, inflammation and cytokines of severe asthma
Source: Eur Respir Mon 2011; 51: 97-106
Year: 2011
Proinflammatory cytokines and IP-10 differentiate neutrophilic and eosinophilic asthma subgroups
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Assessment of anti-inflammatory cytokines in professional lung diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 148s
Year: 2005
Rhinitis, nasal polyposis and asthma: pathological aspects
Source: ISSN=1025-448x, ISBN=1-904097-19-18, page=115
Year: 2001
Investigation of alarmins, interleukin (IL-)23 and IL-36 sputum levels in chronic airway obstructive diseases.
Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Year: 2019
Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease
Source: Eur Respir Monogr 2022; 95: 219-237
Year: 2022
Expression of nasal and bronchial IL-17F and related cytokines in frequent exacerbators with neutrophilic severe asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept